A better consumer experience has implications for clinical improvements, according to a new report from CVS Health. | A ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

Truist raised the firm’s price target on CVS Health (CVS) to $82 from $76 and keeps a Buy rating on the shares as part of a broader research ...

The Arkansas House and Senate have approved a bill that would force pharmacy benefit managers from holding a pharmacy license ...

The stock's fall snapped a three-day winning streak.

Analysts have recently evaluated CVS Health and provided 12-month price targets. The average target is $74.12, accompanied by ...

PBMs in Arkansas may soon face a tough decision as lawmakers propose a bill requiring them to choose between holding a pharmacy license and owning a pharmacy.

Arkansas lawmakers on both sides of the aisle have come together to file a bill that would stop pharmacy benefit managers—the middlemen who negotiate with insur ...

A bill to help independent pharmacies stay open in Alabama unanimously passed both the House and Senate on Tuesday, moving it to the governor's desk.

CVS Health surged 10% intraday and ended yesterday 6% higher. Check out why I think that CVS stock offers a significant ...

CVS Health (CVS) is a top S&P 500 performer in 2025, with year-to-date returns exceeding 50%. Moreover, the stock has shirked ...

A House committee stripped the provision that made PBM executives sweat, but Senate Bill 140 still has some meat.